MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Strona główna・Stock List・Savara Inc

Savara Inc

Closed

SectorHealthcare

5.56 -0.18

Buy Sell

Overview

Share price change

24h

Current

Min

5.53

Max

5.58

Key metrics
By Trading Economics
Income	-2.7M -32M
Employees	70
EBITDA	-3.9M -33M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+84.35% upside

Dividends
By Dow Jones
Next Earnings	11 maj 2026

Market Stats
By TradingEconomics
Market Cap	-71M 1B
Previous open	5.74
Previous close	5.56

News Sentiment

By Acuity

41%

59%

119 / 349 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Neutral Evidence

2.76 / 2.84 Support & Resistance

Savara Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

3 kwi 2026, 04:27 UTC

Major News Events

Singapore PM Warns That Fallout From Mideast War Could Outlast Conflict

5 kwi 2026, 23:55 UTC

Market Talk

Gold Falls Amid Dollar Strength, Inflation Worries -- Market Talk

5 kwi 2026, 23:45 UTC

Market Talk

Nikkei May Decline on Concerns About Energy Costs -- Market Talk

5 kwi 2026, 23:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5 kwi 2026, 23:42 UTC

Market Talk

China's Consumer Inflation Likely Eased in March -- Market Talk

5 kwi 2026, 23:38 UTC

Market Talk

Major News Events

Oil Futures Rise Amid Increased Supply Disruption Concerns -- Market Talk

5 kwi 2026, 12:57 UTC

Major News Events

Some Italian Airports Report Jet-Fuel Shortages -- WSJ

3 kwi 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

3 kwi 2026, 18:30 UTC

Major News Events

An F15-E Just Went Down in Iran. What to Know About the $30 Million Jet. -- Barrons.com

3 kwi 2026, 18:14 UTC

Market Talk

Eli Lilly Seen as Possible GLP-1 Leader With New Pill Approval -- Market Talk

3 kwi 2026, 17:50 UTC

Market Talk

Microsoft's AI Development Will Weigh on Near-Term Azure Growth -- Market Talk

3 kwi 2026, 17:44 UTC

Acquisitions, Mergers, Takeovers

SBA Stock Just Had a Big Day. Why It's Suddenly Hot. -- Barrons.com

3 kwi 2026, 16:50 UTC

Major News Events

An F15-E Just Went Down in Iran. What to Know About the $90 Million Jet. -- Barrons.com

3 kwi 2026, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

3 kwi 2026, 16:12 UTC

Earnings

Oil Stocks Look Tapped Out. Why It's Time to Move Into Other Sectors. -- Barrons.com

3 kwi 2026, 15:56 UTC

Market Talk

Major News Events

Crypto Markets May Be Active Over Holiday Weekend -- Market Talk

3 kwi 2026, 15:56 UTC

Market Talk

Major News Events

Global Equities Roundup: Market Talk

3 kwi 2026, 15:56 UTC

Market Talk

Major News Events

Global Forex and Fixed Income Roundup: Market Talk

3 kwi 2026, 15:20 UTC

Major News Events

Berkshire, Travelers Join U.S. Plan to Insure Shippers in the Hormuz Strait -- Barrons.com

3 kwi 2026, 15:08 UTC

Acquisitions, Mergers, Takeovers

OpenAI Makes Surprise Media Acquisition Ahead of IPO. Why It Will Fail. -- Barrons.com

3 kwi 2026, 14:11 UTC

Market Talk

Major News Events

Oil Shock From War in Iran May Show Up In 2Q Job Growth Data -- Market Talk

3 kwi 2026, 12:56 UTC

Market Talk

Treasury Yields, Dollar Higher Following Robust March Hiring -- Market Talk

3 kwi 2026, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

3 kwi 2026, 08:01 UTC

Market Talk

Global Equities Roundup: Market Talk

3 kwi 2026, 08:01 UTC

Market Talk

Meituan's Profitability Likely to Improve This Year -- Market Talk

3 kwi 2026, 07:45 UTC

Market Talk

LG Electronics Could Post Above-Consensus 1Q Earnings -- Market Talk

3 kwi 2026, 06:17 UTC

Market Talk

Naver Likely to Post Below-Consensus 1Q Earnings -- Market Talk

3 kwi 2026, 06:17 UTC

Market Talk

Global Equities Roundup: Market Talk

3 kwi 2026, 04:33 UTC

Market Talk

China Merchants Port Earnings Likely to Recover This Year -- Market Talk

3 kwi 2026, 04:33 UTC

Market Talk

Global Equities Roundup: Market Talk

Peer Comparison

Price change

Savara Inc Forecast

Price Target

By TipRanks

84.35% upside

12 Months Forecast

Average 10.25 USD 84.35%

High 11 USD

Low 9 USD

Based on 4 Wall Street analysts offering 12 month price targets forSavara Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

4 ratings

Buy

Hold

Sell

Based on 4 analysts giving stock ratings to Savara Inc - Dist in the past 3 months.

Technical Score

By Trading Central

2.76 / 2.84Support & Resistance

The bullish and bearish events are balanced.

All events are bullish.

Bullish events outweigh bearish events.

Sentiment

By Acuity

119 / 349 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Savara Inc

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Langhorne, Pennsylvania.